Cargando…

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

INTRODUCTION: Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients. Cachexia index (CXI) was developed to assess the degree of cachexia in these patients. METHODS: Patients with metastatic NSCLC diagnosed between January 1, 2000, and June 30, 2011, at our institution wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jafri, Syed Hasan Raza, Previgliano, Carlos, Khandelwal, Keerti, Shi, Runhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640427/ https://www.ncbi.nlm.nih.gov/pubmed/26604850 http://dx.doi.org/10.4137/CMO.S30891

Ejemplares similares

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
por: Jafri, Syed H, et al.
Publicado: (2013)

Clinical significance of the cachexia index in patients with small cell lung cancer
por: Go, Se-Il, et al.
Publicado: (2021)

The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review
por: Morita-Tanaka, Satomi, et al.
Publicado: (2023)

Genomic profiling and sites of metastasis in non-small cell lung cancer
por: Chan, Kok Hoe, et al.
Publicado: (2023)

Impact of Cancer Cachexia on Hospitalization-associated Physical Inactivity in Elderly Patients with Advanced Non-small-cell Lung Cancer
por: Morikawa, Ayumu, et al.
Publicado: (2018)

Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non–Small Cell Lung Cancer
por: Demiray, Gökcen, et al.
Publicado: (2017)

Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes
por: White, Rhys, et al.
Publicado: (2020)

Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer
por: Fujii, Hironori, et al.
Publicado: (2022)

Updates on the pathogenesis of advanced lung cancer‐induced cachexia
por: Zhu, Ruifang, et al.
Publicado: (2018)

Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
por: Takayama, Koichi, et al.
Publicado: (2016)

Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer
por: Miyawaki, Taichi, et al.
Publicado: (2022)

Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo
por: Jafri, Syed H, et al.
Publicado: (2010)

Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Cisplatin, Cetuximab, and Radiation in Locally Advanced Head and Neck Squamous Cell Cancer: A Retrospective Review
por: Peddi, Prakash, et al.
Publicado: (2015)

Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis
por: Hakozaki, Taiki, et al.
Publicado: (2022)

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Murata, Daiki, et al.
Publicado: (2023)

Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials
por: Advani, Shailesh M., et al.
Publicado: (2018)

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients
por: Bonomi, Philip, et al.
Publicado: (2019)

Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia
por: Op den Kamp, Celine M, et al.
Publicado: (2015)

Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
por: Salsman, John M., et al.
Publicado: (2014)

Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Matsuo, Norikazu, et al.
Publicado: (2023)

Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
por: Ishioka, Yoshiko, et al.
Publicado: (2023)

Cachexia and advanced dementia
por: Minaglia, Cecilia, et al.
Publicado: (2019)

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
por: Currow, D., et al.
Publicado: (2017)

ADVANCED LUNG CANCER INFLAMMATORY INDEX AS A PROGNOSTIC MARKER FOR OXYGEN REQUIREMENT IN PATIENTS ADMITTED WITH SARS-COV-2 INFECTION
por: SRIDHAR, ARTHI, et al.
Publicado: (2021)

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion
por: Currow, David C., et al.
Publicado: (2018)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
por: Mahajan, Abhishek, et al.
Publicado: (2023)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Palliative radiotherapy for superior vena caval obstruction by lung cancer: A major issue about timing and a minor issue about efficacy
por: Ampil, Federico, et al.
Publicado: (2012)

Current and Emerging Pharmacotherapies for the Treatment of Relapsed Small Cell Lung Cancer
por: Nair, Binu S., et al.
Publicado: (2011)

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2016)

Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
por: Goh, Myung Ji, et al.
Publicado: (2022)

Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study
por: Morimoto, Kenji, et al.
Publicado: (2021)

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
por: Go, Se‐Il, et al.
Publicado: (2021)

Body composition and lung cancer-associated cachexia in TRACERx
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

Advanced breast cancer with cachexia: A case report
por: Liu, Nan, et al.
Publicado: (2021)

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023)

A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
por: Ulas, Arife, et al.
Publicado: (2014)

Comment on 'Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer' by Xie et al.
por: Ding, Ping'an, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ca1h225s131127775gmj5lp68